Injectable biodegradable polycaprolactone-sebacic acid gels for bone tissue engineering

Tissue Engineering - Part A

Volumn 18, Issue 1-2, 2012, Pages 137-146

  Salgado, Christiane L ^a,b   Sanchez, Elisabete M S ^c   Zavaglia, Cecília A C ^c   Almeida, Ana Beatriz ^d   Granja, Pedro L ^c,d  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d Sociedade Brasileira de Pesquisa e Assistência Para A Reabilitação Craniofacial   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BONE; CELL CULTURE; DEGRADATION; FUNCTIONAL POLYMERS; GELS; GENE THERAPY; POLYCAPROLACTONE; STEM CELLS; TISSUE; VEGETABLE OILS;

ALTERNATIVE TECHNOLOGIES; BIOMEDICAL POLYMERS; BONE IMPLANT; BONE IMPLANTATION; BONE TISSUE ENGINEERING; CASTOR OIL; DEGRADATION RATE; HUMAN BODIES; IN-VITRO; IN-VIVO; LOW MOLECULAR WEIGHT; MESENCHYMAL STEM CELL; SEBACIC ACID; SLOW DEGRADATION; TISSUE FUNCTION; TISSUE REGENERATION; TRANSPLANTATION MEDICINE;

TISSUE ENGINEERING;

RATTUS;

ALKALINE PHOSPHATASE; BIOMATERIAL; DECANOIC ACID DERIVATIVE; DICARBOXYLIC ACID; OXAZINE DERIVATIVE; POLYCAPROLACTONE; POLYESTER; RESAZURIN; SEBACIC ACID; XANTHENE DERIVATIVE;

ANIMAL; ARTICLE; BIOREMEDIATION; BONE; CELL CULTURE; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; GEL; HUMAN; IMPLANT; IMPLANTATION; INJECTION; MALE; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PHYSIOLOGY; RAT; TISSUE ENGINEERING; ULTRASTRUCTURE; WISTAR RAT;

ALKALINE PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; BONE AND BONES; CELLS, CULTURED; DECANOIC ACIDS; DICARBOXYLIC ACIDS; GELS; HUMANS; IMPLANTS, EXPERIMENTAL; INJECTIONS; MALE; MESENCHYMAL STEM CELLS; MICROSCOPY, CONFOCAL; OXAZINES; POLYESTERS; PROSTHESIS IMPLANTATION; RATS; RATS, WISTAR; TISSUE ENGINEERING; XANTHENES;

EID: 84855409671     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0294     Document Type: Article

References (40)

1. Payne, R.G., Yaszemski, M.J., Yasko, A.W., and Mikos, A.G. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials 23, 4359, 2002.
2. Bidarra, S.J., Barrias, C.C., Barbosa, M.A., Soares, R., and Granja, P.L. Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. Biomacromolecules 11, 1956, 2010.
3. Evangelista, M.B., Hsiong, S.X., Fernandes, R., Sampaio, P., Kong, H.J., Barrias, C.C., et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. Biomaterials 28, 3644, 2007.
4. Kretlow, J.D., Klouda, L., and Mikos, A.G. Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Delivery Rev 59, 263, 2007.
5. Evangelista, M.B., Hsiong, S.X., Fernandes, R., Sampaio, P., Kong, H.J., Barrias, C.C., Salema, R., Barbosa, M.A., Mooney, D.J., and Granja, P.L. Preosteoblasts growth and differentiation into injectable peptide-functionalized pectin. Biomacromolecules 2011, dx.doi.org/10.1021/bm101110X.
6. Uludag, H., Horvath, V., Black, J.P., and Sefton, M.V. Viability and protein secretion from human hepatoma (Hepg2) cells encapsulated in 400-Mu-M polyacrylate microcapsules by submerged nozzle liquid jet extrusion. Biotechnol Bioeng 10, 1199, 1994.
7. Kweon, H., Yoo, M.K., Park, I.K., Kim, T.H., Lee, H.C., Lee, H.S., et al. A novel degradable polycaprolactone networks for tissue engineering. Biomaterials 24, 801, 2003.
8. Fonseca, K.B., Bidarra, S.J., Oliveira, M.J., Granja, P.L., and Barrias, C.C. Molecularly designed alginate hydrogels susceptible to local proteolysis as three-dimensional cellular microenvironments. Acta Biomaterialia 7, 1674, 2011.
9. Grellier, M., Granja, P.L., Fricain, J.C., Bidarra, S.J., Renard, M., Bareille, R., et al. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 30, 3271, 2009.
10. Hench, L.L., Polak, J.M., Xynos, I.D., and Buttery, L.D.K. Bioactive materials to control cell cycle. Mater Res Innov 3, 313, 2000.
11. Chu, C.C. Biodegradable Polymeric Biomaterials: An Updated Overview. In: Bronzino, J.D., ed. Biomedical Engineering Handbook, 2nd edition. Boca Raton, FL: CRC Press, 2000, pp. 1-22.
12. Ratner, B.D. New ideas in biomaterials science-a path to engineered biomaterials. J Biomed Mater Res 27, 837, 1993.
13. Luciano, R.M., Zavaglia, C.A.C., Duek, E.A.R., and Alberto-Rincon, M.C. Synthesis and characterization of poly(L-lactic acid) membranes: studies in vivo and in vitro. J Mater Sci Mater Med 14, 87, 2003.
14. Williams, J.M., Adewunmi, A., Schek, R.M., Flanagan, C.L., Krebsbach, P.H., Feinberg, S.E., Hollister, S.J., and Das, S. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 23, 4817, 2005.
15. Mano, J.F., Sousa, R.A., Boesel, L.F., Neves, N.M., and Reis, R.L. Bloinert, biodegradable and injectable polymeric matrix composites for hard tissue replacement: state of the art and recent developments. Compos Sci Technol 64, 789, 2004.
16. Barbanti, S.H., Santos, A.R., Zavaglia, C.A.C., and Duek, E.A.R. Porous and dense poly(L-lactic acid) and poly(D,Llactic acid co-glycolic acid) scaffolds: in vitro degradation in culture medium and osteoblasts culture. J Mater Sci Mater Med 15, 1315, 2004.
17. Li, S.M., Chen, X.H., Gross, R.A., and McCarthy, S.P. Hydrolytic degradation of PCL/PEO copolymers in alkaline media. J Mater Sci Mater Med 11, 227, 2000.
18. Vert, M., Li, S.M., Spenlehauer, G., and Guerin, P. Bioresorbability and biocompatibility of aliphatic polyesters. J Mater Sci Mater Med 3, 432, 1992.
19. Lam, C.X.F., Hutmacher, D.W., Schantz, J.T., Woodruff, M.A., and Teoh, S.H. Evaluation of polycaprolactone scaffold degradation for 6 months in vitro and in vivo. J Biomed Mater Res Part A 90A, 906, 2009.
20. Salgado, C.L., Sanchez, E.S., Zavaglia, C.A.C., and Granja, P.L. Método De Confecção De Polímero Biodegradável Injeta ́vel Brazil: Brazilian submitted patent: PI 018080059526, 2009.
21. Standardization of Biological Evaluation of Medical Devices. Part 5: Tests for Cytotoxicity: In Vitro Methods, Volume 10993-5. In: ISO, ed. Geneva, Switzerland, 1999.
22. Ashton, B.A., Abdullah, F., Cave, J., Williamson, M., Sykes, B.C., Couch, M., et al. Characterization of cells with high alkaline-phosphatase activity derived from human-bone and marrow-preliminary assessment of their osteogenicity. Bone 6, 313, 1985.
23. Barrias, C.C., Lamghari, M., Granja, P.L., Sa Miranda, M.C., and Barbosa, M.A. Biological evaluation of calcium alginate microspheres as a vehicle for the localized delivery of a therapeutic enzyme. J Biomed Mater Res 72, 57, 2005.
24. Ciapetti, G., Ambrosio, L., Marletta, G., Baldini, N., and Giunti, A. Human bone marrow stromal cells: in vitro expansion and differentiation for bone engineering. Biomaterials 27, 6150, 2006.
25. Vitte, J., Benoliel, A.M., Pierres, A., and Bongrand, P. Is there a predictable relationship between surface physical-chemical properties and cell behaviour at the interface? Eur Cell Mater 7, 52, 2004.
26. Luttikhuizen, D.T., Harmsen, M.C., and Van Luyn, M.J.A. Cellular and molecular dynamics in the foreign body reaction. Tissue Eng 12, 1955, 2006.
27. Chang, D.T., Jones, J.A., Meyerson, H., Colton, E., Kwon, I.K., Matsuda, T., et al. Lymphocyte/macrophage interactions: Biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res Part A 87A, 676, 2008.
28. Rodriguez, A., Meyerson, H., and Anderson, J.M. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. J Biomed Mater Res Part A 89A, 152, 2009.
29. Ratner, B.D., Hoffman, A.S., Schoen, F.J., and Lemons, J.E. Biomaterials Science: An Introduction to Materials in Medicine. London: Academic Press, 1995.
30. Woodruff, M.A., and Hutmacher, D.W. The return of a forgotten polymer-polycaprolactone in the 21st century. Progr Polym Sci 35, 1217, 2010.
31. Woodward, S.C., Brewer, P.S., Moatamed, F., Schindler, A., and Pitt, C.G. The intracellular degradation of poly(epsiloncaprolactone). J Biomed Mater Res 19, 437, 1985.
32. Albertson, A.C. Controlled degradation by artificial and biological processes. In: Hatada. K., Kitayama, T., and Vogl, O., eds. Macromolecular Design of Polymeric Materials. New York, Basel, Hong Kong: Marcel Dekker Inc., 1997, pp. 739-780.
33. Jabbari, E., Wang, S.F., Lu, L.C., Gruetzmacher, J.A., Ameenuddin, S., Hefferan, T.E., et al. Synthesis, material properties, and biocompatibility of a novel self-crosslinkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold. Biomacromolecules 6, 2503, 2005.
34. Martina, M., and Hutmacher, D.W. Biodegradable polymers applied in tissue engineering research: a review. Polym Int 56, 145, 2007.
35. Shikanov, A., Vaisman, B., Krasko, M.Y., Nyska, A., and Domb, A.J. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity. J Biomed Mater Res Part A 69A, 47, 2004.
36. Shikanov, A., and Domb, A.J. Poly(sebacic acid-co-ricinoleic acid) biodegradable injectable in situ gelling polymer. Biomacromolecules 7, 288, 2006.
37. Modi, S., Jain, J.P., Domb, A.J., and Kumar, N. Copolymers of pharmaceutical grade lactic acid and sebacic acid: drug release behavior and-biocompatibility. Eur J Pharm Biopharm 64, 277, 2006.
38. Clark, R.A.F.,Ghosh,K., and Tonnesen,M.G. Tissue engineering for cutaneous wounds. J Invest Dermatol 127, 1018, 2007.
39. Salgado, A.J., Coutinho, O.P., and Reis, R.L. Bone tissue engineering: state of the art and future trends. Macromol Biosci 4, 743, 2004.
40. Sawyer, A.A., Song, S.J., Susanto, E., Chuan, P., Lam, C.X.F., Woodruff, M.A., et al. The stimulation of healing within a rat calvarial defect by mPCL-TCP/collagen scaffolds loaded with rhBMP-2. Biomaterials 30, 2479, 2009.